BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 91.04% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.04% | -- | -- | -- | -- |
| Cost of Revenue | 83.72% | 27.44% | -7.52% | 89.51% | 19.18% |
| Gross Profit | -82.63% | -11.43% | 17.78% | -66.48% | -3.62% |
| SG&A Expenses | 13.98% | 14.08% | 41.22% | 52.96% | 94.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.27% | 24.21% | 1.79% | 78.03% | 39.68% |
| Operating Income | -54.29% | -12.07% | 6.51% | -62.23% | -28.35% |
| Income Before Tax | -72.13% | -22.78% | 13.82% | -58.77% | 0.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.13% | -22.78% | 13.82% | -58.77% | 0.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.13% | -22.78% | 13.82% | -58.77% | 0.49% |
| EBIT | -54.29% | -12.07% | 6.51% | -62.23% | -28.35% |
| EBITDA | -54.26% | -12.00% | 6.56% | -62.37% | -28.40% |
| EPS Basic | -45.26% | -22.21% | 91.60% | 92.42% | 95.36% |
| Normalized Basic EPS | -45.25% | -22.20% | 91.60% | 92.42% | 95.26% |
| EPS Diluted | -45.26% | -22.21% | 91.60% | 92.42% | 95.36% |
| Normalized Diluted EPS | -45.25% | -22.20% | 91.60% | 92.42% | 95.26% |
| Average Basic Shares Outstanding | 18.50% | 0.47% | 925.87% | 1,995.27% | 2,042.22% |
| Average Diluted Shares Outstanding | 18.50% | 0.47% | 925.87% | 1,995.27% | 2,042.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |